Impact of HPV Vaccination on Cervical Cancer in Finland
Author Information
Author(s): Barnabas Ruanne V, Laukkanen Päivi, Koskela Pentti, Kontula Osmo, Lehtinen Matti, Garnett Geoff P
Primary Institution: Cancer Epidemiology Unit, University of Oxford
Hypothesis
How will HPV vaccination affect cervical cancer rates in Finland?
Conclusion
HPV vaccination has the potential to significantly decrease HPV type-specific cervical cancer incidence.
Supporting Evidence
- HPV vaccines have shown 90%-100% efficacy in preventing HPV infection in trials.
- Vaccinating 90% of young women before sexual debut could decrease cervical cancer incidence by 91%.
- Changes in sexual behavior and smoking contributed to increased cervical cancer rates among Finnish women.
Takeaway
Vaccinating young women against HPV can help prevent cervical cancer. If many women get vaccinated before they start having sex, it can reduce cancer cases a lot.
Methodology
A mathematical model was developed to estimate HPV transmission and cervical cancer incidence based on Finnish data.
Potential Biases
Potential biases in self-reported sexual behavior and underreporting of sensitive data.
Limitations
The model relies on assumptions about sexual behavior and vaccine efficacy, which may not fully capture real-world complexities.
Participant Demographics
The study focused on Finnish women, particularly those aged 30-39.
Statistical Information
P-Value
0.6
Confidence Interval
95% CI, 90%-100%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website